SMTL ID : 9by6.1

Crystal structure of the kinase domain of EGFR soaked with non-covalent osimertinib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.55 Å

Oligo State

monomer

Ligands

1 x PDO: 1,3-PROPANDIOL(Covalent)

PDO.1: 9 residues within 4Å: Chain A: R.152, M.197, A.198, S.201, Y.207, T.208, S.211, D.212, S.215 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:A.198, A:S.201, A:T.208

1 x YY3: N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide(Non-covalent)

YY3.2: 14 residues within 4Å: Chain A: L.34, G.35, F.39, V.42, A.59, Q.107, L.108, M.109, P.110, G.112, C.113, D.116, E.120, L.160 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:F.39, A:A.59, A:L.160 Hydrogen bonds: A:M.109, A:M.109, A:C.113 Salt bridges: A:E.120

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tsutsui, Y. et al., Comprehensive characterization of EGFR-tyrosine kinase inhibitor interactions probed by hydrogen-deuterium exchange and mass spectrometry (HDX-MS). To Be Published

Release Date

2025-05-28

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence